Association of Apo E gene polymorphism with HDL level in Tehranian population

European Journal of Lipid Science and Technology

Volumn 112, Issue 7, 2010, Pages 810-816

  Daneshpour, Maryam S ^a   Hedayati, Mehdi ^a   Eshraghi, Parisa ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apo E polymorphism; HDL C; Iran; TLGS

Indexed keywords

EID: 77956945329     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200900207     Document Type: Article

References (43)

1. Weisgraber, K. H., Apolipoprotein, E., Structure-function relationships. Adv. Protein Chem. 1994, 45, 249-302.
2. Miettinen, H. E., Korpela, K., Hamalainen, L., Kontula, K., Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum. Genet. 1994, 94, 189-192.
3. Utermann, G., Hees, M., Steinmetz, A., Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 1977, 269, 604-607.
4. Zannis, V. I., Breslow, J. L., Utermann, G., Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J. Lipid Res. 1982, 23, 911-914.
5. Vaisi-Raygani, A., Kharrazi, H., Rahimi, Z., Pourmotabbed, T., Frequencies of apolipoprotein E polymorphism in a healthy Kurdish population from Kermanshah, Iran. Hum. Biol. 2007, 79, 579-587.
6. Raygani, A. V., Rahimi, Z., Kharazi, H., Tavilani, H., Pourmotabbed, T., Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neurosci. Lett. 2006, 408, 68-72.
7. Raygani, A. V., Zahrai, M., Raygani, A. V., Doosti, M., et al., Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci. Lett. 2005, 375, 1-6.
8. Kharrazi,H., Vaisi Raygani, A., Sabokroh, A. R., Pourmotabbed, T., Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran. Clin. Biochem. 2006, 39, 613-616.
9. Tan, C. E., Tai, E. S., Tan, C. S., Chia, K. S., et al., APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis 2003, 170, 253-260.
10. Frikke-Schmidt, R., Nordestgaard, B. G., Agerholm-Larsen, B., Schnohr, P., Tybjaerg-Hansen, A., Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J. Lipid Res. 2000, 41, 1812-1822.
11. Davignon, J., Gregg, R. E., Sing, C. F., Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8, 1-21.
12. Lussier-Cacan, S., Bolduc, A., Xhignesse, M., Niyonsenga, T., Sing, C. F., Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype. Arterioscler. Throm. Vasc. Biol. 2002, 22, 824-831.
13. Ordovas, J. M., Lopez-Miranda, J., Mata, P., Perez-Jimenez, F., et al., Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 1995, 118, S11-S27.
14. Azizi, F., Rahmani, M., Emami, H., Mirmiran, P., et al., Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (phase 1). Soz. Praventivmed. 2002, 47, 408-426.
15. Azizi, F., Mirmiran, P., Azadbakht, L., Predictors of cardiovascular risk factors in Tehranian adolescents: Tehran Lipid and Glucose Study. Int. J. Vitam. Nutr. Res. 2004, 74, 307-312.
16. Azizi, F., Emami, H., Salehi, P., Ghanbarian, A., et al., Cardiovascular risk factors in the elderly: The Tehran Lipid and Glucose Study. J. Cardiovasc. Risk 2003, 10, 65-73.
17. Warnick, G. R., Benderson, J., Albers, J. J., Dextran sulfate-Mg2+ precipitation procedure for quantitation of highdensity-lipoprotein cholesterol. Clin. Chem. 1982, 28, 1379-1388.
18. Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., Eder, H. A., Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J. Lipid Res. 1982, 23, 1206-1223.
19. Friedewald, W. T., Levy, R. I., Fredrickson, D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502.
20. Truett, G. E., Heeger, P., Mynatt, R. L., Truett, A. A., et al., Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 2000, 29, 54.
21. Emi, M., Wu, L. L., Robertson, M. A., Myers, R. L., et al., Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988, 3, 373-379.
22. Liu, K., Muse, S. V., PowerMarker: An integrated analysis environment for genetic marker analysis. Bioinformatics 2005, 21, 2128-2129.
23. Kokubo, Y., Tanaka, H., Apolipoprotein E genetic polymorphism. Nippon Rinsho 2001, 59, 799-805.
24. Burman, D., Mente, A., Hegele, R. A., Islam, S., et al., Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada. Atherosclerosis 2008, 203, 192-200.
25. Muros, M., Rodri{dotless}́guez-Ferrer, C., Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis 1996, 121, 13-21.
26. Gordon, D. J., Rifkind, B. M., High-density lipoprotein-the clinical implications of recent studies. N. Engl. J. Med. 1989, 321, 1311-1316.
27. Azizi, F., Raiszadeh, F., Salehi, P., Rahmani, M., et al., Determinants of serum HDL-C level in a Tehran urban population: The Tehran Lipid and Glucose Study. Nutr. Metab. Cardiovasc. Dis. 2002, 12, 80-89.
28. Peacock, J. M., Arnett, D. K., Atwood, L. D., Myers, R. H., et al., Genome scan for quantitative trait loci linked to highdensity lipoprotein cholesterol: The NHLBI family heart study. Arterioscler. Throm. Vasc. Biol. 2001, 21, 1823-1828.
29. Fumeron, F., Aubert, R., Siddiq, A., Betoulle, D., et al., Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004, 53, 1150-1157.
30. Daneshpour, M., Hedayati, M., Azizi, F., Hepatic lipase C-514T polymorphism and its association with high-density lipoprotein cholesterol level in Tehran. Eur. J. Cardiovasc. Prev. Rehabil. 2006, 13, 101-103.
31. Daneshpour, M., Hedayati, M., Azizi, F., TaqI B1/B2 and-629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS). Genet. Mol. Bio. 2007, 30, 1039-1046.
32. Lahoz, C., Osgood, D., Wilson, P. W. F., Schaefer, E. J., Ordovas, J. M., Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study. Clin. Chem. 1996, 42, 1817-1823.
33. Pena, R., Mostaza, J. M., Lahoz, C., Jimenez, J., et al., Apo E polymorphism and coronary heart disease. Clin. Med. 2001, 116, 681-685.
34. Kolovou, G. D., Daskalova, D., Hatzivassiliou, M., Yiannakouris, N., et al., The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population-Implications for the interpretation of similar studies. Angiology 2003, 54, 51-58.
35. Corder, E. H., Woodbury, M. A., Genetic heterogeneity in Alzheimer's disease: A grade of membership analysis. Genet. Epidemiol. 1993, 10, 495-499.
36. Bretsky, P., Guralnik, J. M., Launer, L., Albert, M., Seeman, T. E., The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging. Neurology 2003, 60, 1077-1081.
37. Gomez-Coronado, D., Alvarez, J. J., Entrala, A., Olmos, J. M., et al., Apolipoprotein E polymorphism in men and women from a Spanish population: Allele frequencies and influence on plasma lipids and apolipoproteins. Atherosclerosis 1999, 147, 167-176.
38. Hanis, C. L., Hewett-Emmett, D., Douglas, T. C., Bertin, T. K., Schull, W. J., Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Arterioscler. Throm. 1991, 11, 362-370.
39. Kamboh, M. I., Aston, C. E., Hamman, R. F., The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 1995, 112, 145-159.
40. Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., et al., Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298, 1300-1311.
41. Vaisi-Raygani, A., Rahimi, Z., Nomani, H., Tavilani, H., Pourmotabbed, T., The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin. Biochem. 2007, 40, 1150-1156.
42. Gronroos, P., Raitakari, O. T., Kahonen, M., Hutri-Kahonen, N., et al., Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: A 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study. Clin. Chem. Lab. Med. 2007, 45, 592-598.
43. Djousse, L., Myers, R. H., Province, M. A., Hunt, S. C., et al., Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 2002, 33, 1357-1361.